As of 2025-03-16, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (36.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -720.2%.
The range of the Relative Valuation is (30.12) - (46.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.3x - 47.9x | 41.2x |
| Forward P/E multiples | 26.9x - 48.6x | 34.5x |
| Fair Price | (30.12) - (46.09) | (36.41) |
| Upside | -613.2% - -885.2% | -720.2% |
| Date | P/E |